Detecting placebo and drug effects on Parkinson's disease symptoms by longitudinal item‐score models
Abstract This study tested the hypothesis that analyzing longitudinal item scores of the Unified Parkinson's Disease Rating Scale could allow a smaller trial size and describe a drug's effect on symptom progression. Two historical studies of the dopaminergic drug ropinirole were analyzed:...
Saved in:
Main Authors: | Chao Chen (Author), Siv Jönsson (Author), Shuying Yang (Author), Elodie L. Plan (Author), Mats O. Karlsson (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2021-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A disease model predicting placebo response and remission status of patients with ulcerative colitis using modified Mayo score
by: Anita Moein, et al.
Published: (2023) -
Application of longitudinal item response theory models to modeling Parkinson's disease progression
by: Haotian Zou, et al.
Published: (2022) -
Item response theory analysis of daytime sleepiness as a symptom of obstructive sleep apnea
by: Gustaf J. Wellhagen, et al.
Published: (2024) -
Predicting the longitudinal changes of levodopa dose requirements in Parkinson's disease using item response theory assessment of real‐world Unified Parkinson's Disease Rating Scale
by: Dongwoo Chae, et al.
Published: (2021) -
Latent-variable Approaches Utilizing Both Item Scores and Response Times To Detect Test Fraud
by: Sinharay Sandip
Published: (2021)